US sharemarkets soared on Monday. Drugmaker Moderna’s shares rallied by 20% after the company reported “positive” phase one results for a potential COVID-19 vaccine.
Post Views: 144
US sharemarkets soared on Monday. Drugmaker Moderna’s shares rallied by 20% after the company reported “positive” phase one results for a potential COVID-19 vaccine.